Sloan School of Management, Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America.
Department of Economics, Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America.
PLoS One. 2019 Mar 15;14(3):e0213373. doi: 10.1371/journal.pone.0213373. eCollection 2019.
There is widespread concern over the health risks and healthcare costs from potentially inappropriate high-cost imaging. As a result, the Centers for Medicare and Medicaid Services (CMS) will soon require high-cost imaging orders to be accompanied by Clinical Decision Support (CDS): software that provides appropriateness information at the time orders are placed via a best practice alert for targeted (i.e. likely inappropriate) imaging orders, although the impacts of CDS in this context are unclear. In this randomized trial of 3,511 healthcare providers at Aurora Health Care, we study the impacts of CDS on the ordering behavior of providers. We find that CDS reduced targeted imaging orders by a statistically significant 6%, however there was no statistically significant change in the total number of high-cost scans or of low-cost scans. The results suggest that the impending CMS mandate requiring healthcare systems to adopt CDS may modestly increase the appropriateness of high-cost imaging.
人们普遍担心潜在的不适当高成本成像带来的健康风险和医疗保健成本。因此,医疗保险和医疗补助服务中心(CMS)将很快要求高成本成像订单附有临床决策支持(CDS):在下达订单时,通过针对特定(即可能不适当)成像订单的最佳实践警报提供适当性信息的软件,尽管在这种情况下 CDS 的影响尚不清楚。在这项针对 Aurora Health Care 3511 名医疗保健提供者的随机试验中,我们研究了 CDS 对提供者订购行为的影响。我们发现,CDS 使有针对性的成像订单减少了 6%,但总成本高的扫描或低成本的扫描数量没有统计学上的显著变化。结果表明,即将出台的 CMS 授权要求医疗系统采用 CDS 可能会适度提高高成本成像的适当性。